News

Das News Magazin des Schweizer Fernsehen SRF 1 berichtete im Format der Spätabendsendung über die Forschung von Botond Roska

Botond Roska sprach mit Wissenschaftsredaktorin Irène Dietschi im Radio SRF1 über den aktuellen Stand der Bemühungen, Blinden wieder eine gewisse Sehfähigkeit zurück zu geben.

Find a brochure about the awardee & project, a movie and a podcast.

Die Broschüre, den Film und einen Podcast über den Preisträger gibt es auch in Deutsch!

Interviews der 'Weltwoche' und des 'St Galler Tagblatts' mit Peter Maloca über neue Technologien der Augenheilkunde, wie sie auch Riesen der internationalen Gaming-Industrie nutzen

Congratulations for the „Best Experimental Work“ 2020!

Please join Carlo Rivolta's public inaugural lecture as professor at the University of Basel - live at the Naturhistorisches Museum Basel, or on YouTube

Together with Beam Therapeutics, in a program led by Bence György and Botond Roska at IOB, we will develop precision genetic medicines through base editing.

The genetic origin of a previously-unrecognized syndrome leading to severe, multiple disabilities in children reveals a potential opportunity for treatment.

A study validates the ability of virtual reality (VR) to provide similar quantitative data in ophthalmology and beyond as physical measurements, alongside the added benefit of VR interfaces.

Congratulations to our co-director and Head of our Molecular Research Center! He is to receive one of the world's most highly endowed research prizes.

An exciting new approach to understanding human disease across multiple organ systems is now published in Stem Cell Reports.

A new strategy for reversing vision loss from macular degeneration, inspired by infrared vision in snakes, and based on gene therapy and nanotechnology, is published in Science.

A study now published in JAMA Ophthalmology with the participation of the University of Basel and IOB shows that microperimetry testing can be used to determine whether novel treatments are efficacious in slowing down vision loss.

Digital retinal vessel diameter and wall analysis may improve accuracy of cardiovascular risk stratification, a study in TVST shows.

The project has been awarded the maximum funding for individual projects. The race for selection was very competitive: 13% of all projects submitted have been funded; in biomedicine only 22 out of 169.

The University of Basel awarded our group leader Ophthalmic Imaging the title of a 'Privatdozent'. Congratulations!